Moderna Stock No-Brainer After FDA Win: Buy or Not?
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Converting to a Roth IRA can provide tax diversification, tax-free qualified withdrawals, and greater retirement flexibility.
19,609 articlesA recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Ripple's XRP is edging higher as derivatives data shows falling open interest. Traders wonder whether this is short-c...
Tesla and BYD diverge in 2026 as margin expansion and AI investments clash with export growth and battery integration...
Meta quietly positions itself as the strongest mega-cap alternative this summer, leveraging ad momentum and a new AI ...
Space investors are watching a highly anticipated IPO-style moment as SpaceX nears price levels. This guide breaks do...
Comfort Systems USA is set to report Q4 FY2025 after the bell, with shares up about 65% over the past year. Analysts ...
Lucid Group delivered a stronger top line in Q4, but cash burn remains a key hurdle. Investors will parse the mix of ...
A rally in Cava lifted the restaurant group, but Sweetgreen’s disappointing sales offer pulled markets back, undersco...
Palantir’s latest quarter reported strong numbers and rising defense-related AI demand, boosting the stock and signal...
Palantir Technologies stock popped on a rally driven by legal news and AI momentum. This guide explains what happened...
Barclays just boosted its Oracle price target to $240, highlighting a sharper focus on Oracle's cloud expansion and A...
PayPal is widening access to PYUSD, allowing users in 70 countries to hold and move its stablecoin. The shift could c...